Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non-squamous NSCLC

Clinical trial NCT02852798 · UNKNOWN

Trial details

NCT number: NCT02852798
Sponsor: Jiangsu ShengDiYa Medicine Co., Ltd.
Status: UNKNOWN
Study type: OBSERVATIONAL

Nonsquamous Nonsmall Cell Neoplasm of Lung

Start date: 2016-08-01
Primary completion: 2017-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.